Kangtai Bio Releases 2026 Interim Report with Net Profit of 50.3861 Million Yuan

Earnings
โดย Jiemian·CN·Read original
Summary · why it matters

Kangtai Bio released its 2026 interim report, with net profit attributable to the parent company of 50.3861 million yuan. The company's total operating revenue was 1.273 billion yuan, down 8.55% from the same period last year. Net cash inflow from operating activities was 24.7039 million yuan, down 67.32% year-on-year. The company's latest asset-liability ratio was 30.64%, gross margin was 71.33%, ROE was 0.52%, and diluted earnings per share was 0.05 yuan.

Impact on stocks 1

Others▼ · 1 stocks
© 2026 MarketDXNews